| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Medical Officer | Chief Medical Officer
1 company
Golden Lee Scott serves as an EVP &Chief Medical Officer at PTCT. Across recent SEC filings that breaks down to 0 buys and 15 sells. Those positions are worth an estimated $5.4M at current prices.
Historically, Golden Lee Scott's trades have earned a below-average insider score of 43/100 across 15 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -51.9%.
The biggest single holding is PTCT (~$5.4M) as EVP &Chief Medical Officer. The recent filings there lean toward selling, a net 23,524 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 9, 2024 | PTCT Ptc Therapeutics, Inc. | Chief Medical Officer | Sell10b5-1 | 2,000 | $28.87 | $57,739.36 | -5.0% | -6.4% | +56.9% |